Table 1.
Flora analysis (mean ± SD, Lg10n/g)
| Index |
BIFICO group |
Placebo group |
||
| Pretreatment (n = 15) | Post-treatment (n = 15) | Pretreatment (n = 15) | Post-treatment (n = 15) | |
| EMB | 8.21 ± 0.69 | 8.11 ± 0.29 | 8.23 ± 0.42 | 8.93 ± 0.62ac |
| EC | 6.63 ± 0.21 | 7.20 ± 0.31a | 6.71 ± 0.39 | 6.67 ± 0.48c |
| SP | 3.55 ± 0.96 | 3.61 ± 0.19 | 3.65 ± 0.41 | 3.72 ± 0.30 |
| SB | 3.45 ± 0.83 | 3.09 ± 0.25a | 3.36 ± 0.35 | 3.47 ± 0.96 |
| BD | 6.79 ± 0.29 | 7.26 ± 0.03a | 6.77 ± 0.88 | 6.81 ± 0.35 |
| BL | 6.92 ± 0.34 | 7.69 ± 0.34b | 7.03 ± 0.34 | 6.44 ± 0.25bd |
| PS | 7.26 ± 0.61 | 7.32 ± 0.74 | 6.78 ± 0.59 | 6.93 ± 0.52 |
| LC | 6.95 ± 0.52 | 7.39 ± 0.72a | 7.07 ± 0.97 | 6.67 ± 0.43c |
| ES | 5.91 ± 0.92 | 5.45 ± 0.25 | 5.45 ± 0.67 | 5.68 ± 0.80 |
| CD | 6.18 ± 0.78 | 6.13 ± 0.66 | 6.19 ± 0.72 | 6.37 ± 0.96 |
a
P < 0.05,
b
P < 0.01 vs post-treatment; cP < 0.05,
d
P < 0.01 vs control. EMB: Enterobactera; EC: Enterococcus; SP: Staphylococcus; SB: Sac-charomyces (yeast); BD: Bacteroides; BL: Bifidobacterium; LC: Lactobacillus; PS: Peptococcus; ES: Eubacterium; CD: Clostridium.